Furthermore, GluA2 Q/R site editing is impaired in Alzheimer’s disease (AD), raising the possibility that unedited GluA2(Q)-containing AMPARs contribute to synapse loss and neurodegeneration in AD. The gene discussed is GRIA2; the disease is early-onset autosomal dominant Alzheimer disease.